Moffitt advances patient avatar technologies through $15M federal research initiative

COA survey finds high bispecific therapy adoption among community oncology practices

The Community Oncology Alliance announced results from a national survey examining how independent community oncology practices deliver bispecific therapies on Sept. 22.

September 25, 2026

Vol.52 No.35

In Brief

Moffitt Cancer Center launches radiopharma program to speed research, clinical translation, manufacturing

Moffitt Cancer Center and Speros have launched the Moffitt Radiopharmaceutical Program, an interdisciplinary initiative that accelerates radiopharmaceutical research, development, clinical translation and manufacturing at Speros and positions the 775-acre life sciences campus to be the leading hub for radiopharmaceutical innovation in the Southeast.

September 11, 2026

Vol.52 No.33

Cancer Policy

HRSA redrafts 340B rebate pilot program after courts block the original version

After returning to the drawing board, the Health Resources and Services Administration has announced a second iteration of the 340B Rebate Model Pilot Program, after it withdrew the original pilot earlier this year.

BTK A428D mutation allows blood cancers to outsmart BTK-targeted therapies, study finds

A team of investigators have uncovered a rare genetic mutation that enables some blood cancers to evade both approved Bruton tyrosine kinase inhibitors and newer BTK degraders.

July 31, 2026

Vol.52 No.30

Clinical Roundup

Moffitt-led team develops chemical approach to build safer precision medicines

Researchers at Moffitt Cancer Center have developed a chemical approach that could help make targeted cancer medicines safer and more precise.

July 31, 2026

Vol.52 No.30

In Brief

The V Foundation announces recipients of the 2026 Breaking Barriers in Cancer Research Award

The V Foundation for Cancer Research, a top-rated cancer research charity, announced $11.2 million in funding awarded to 14 scientists through its 2026 Breaking Barriers in Cancer Research Award program.

July 24, 2026

Vol.52 No.29

Moffitt advances patient avatar technologies through $15M federal research initiative

YOU MAY BE INTERESTED IN

COA survey finds high bispecific therapy adoption among community oncology practices

Moffitt Cancer Center launches radiopharma program to speed research, clinical translation, manufacturing

HRSA redrafts 340B rebate pilot program after courts block the original version

BTK A428D mutation allows blood cancers to outsmart BTK-targeted therapies, study finds

Moffitt-led team develops chemical approach to build safer precision medicines

The V Foundation announces recipients of the 2026 Breaking Barriers in Cancer Research Award

Renew today!

Subscriber content

Never miss an issue!

Login